Skadden is representing Pfizer in the $11.85 billion divestiture of its infant-nutrition business to Nestlé, announced on April 23.
Skadden is representing Pfizer in the $11.85 billion divestiture of its infant-nutrition business to Nestlé, announced on April 23.